Study: bioTheranostics CancerTYPE ID Classifies 30 Main Tumor Types
bioTheranostics has published study results related to its 92-gene molecular classification test to aid in the determination of the origin of a tumor.
Read MoreSearch Results for: lung cancer
In Your Lifetime
Judy O’Rourke We wish we could be across the room, asking what you think about things. Plan B is the recent survey we conducted in partnership with the research department at Mizuho Securities USA, asking where you think personalized med
Read More
Unique as a Fingerprint
Update on how some companies are embracing personalized medicine in oncology testing
Read MoreAbbott Receives FDA Clearance for ALK FISH Test
The new Abbott Vysis ALK Break Apart FISH Probe test is designed to identify ALK-positive NSCLC patients for Pfizer’s approved NSCLC therapy, XALKORI (crizotinib), an oral ALK inhibitor.
Read More
Biocare’s Legacy: Diagnostic Power Through Multiplex IHC
Biocare Medical’s innovations are grounded in patient care, says David Tacha, HTL (ASCP), PhD, vice president of R&D, chief scientific officer, and one of the company’s founders. When you walk into the lab of David Tacha, HTL (ASCP), P
Read More